Cargando…

Collaborative Drug Therapy Management: Case Studies of Three Community-Based Models of Care

Collaborative drug therapy management agreements are a strategy for expanding the role of pharmacists in team-based care with other providers. However, these agreements have not been widely implemented. This study describes the features of existing provider–pharmacist collaborative drug therapy mana...

Descripción completa

Detalles Bibliográficos
Autores principales: Snyder, Margie E., Earl, Tara R., Gilchrist, Siobhan, Greenberg, Michael, Heisler, Holly, Revels, Michelle, Matson-Koffman, Dyann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4375988/
https://www.ncbi.nlm.nih.gov/pubmed/25811494
http://dx.doi.org/10.5888/pcd12.140504
_version_ 1782363661794279424
author Snyder, Margie E.
Earl, Tara R.
Gilchrist, Siobhan
Greenberg, Michael
Heisler, Holly
Revels, Michelle
Matson-Koffman, Dyann
author_facet Snyder, Margie E.
Earl, Tara R.
Gilchrist, Siobhan
Greenberg, Michael
Heisler, Holly
Revels, Michelle
Matson-Koffman, Dyann
author_sort Snyder, Margie E.
collection PubMed
description Collaborative drug therapy management agreements are a strategy for expanding the role of pharmacists in team-based care with other providers. However, these agreements have not been widely implemented. This study describes the features of existing provider–pharmacist collaborative drug therapy management practices and identifies the facilitators and barriers to implementing such services in community settings. We conducted in-depth, qualitative interviews in 2012 in a federally qualified health center, an independent pharmacy, and a retail pharmacy chain. Facilitators included 1) ensuring pharmacists were adequately trained; 2) obtaining stakeholder (eg, physician) buy-in; and 3) leveraging academic partners. Barriers included 1) lack of pharmacist compensation; 2) hesitation among providers to trust pharmacists; 3) lack of time and resources; and 4) existing informal collaborations that resulted in reduced interest in formal agreements. The models described in this study could be used to strengthen clinical–community linkages through team-based care, particularly for chronic disease prevention and management.
format Online
Article
Text
id pubmed-4375988
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-43759882015-04-17 Collaborative Drug Therapy Management: Case Studies of Three Community-Based Models of Care Snyder, Margie E. Earl, Tara R. Gilchrist, Siobhan Greenberg, Michael Heisler, Holly Revels, Michelle Matson-Koffman, Dyann Prev Chronic Dis Special Topic Collaborative drug therapy management agreements are a strategy for expanding the role of pharmacists in team-based care with other providers. However, these agreements have not been widely implemented. This study describes the features of existing provider–pharmacist collaborative drug therapy management practices and identifies the facilitators and barriers to implementing such services in community settings. We conducted in-depth, qualitative interviews in 2012 in a federally qualified health center, an independent pharmacy, and a retail pharmacy chain. Facilitators included 1) ensuring pharmacists were adequately trained; 2) obtaining stakeholder (eg, physician) buy-in; and 3) leveraging academic partners. Barriers included 1) lack of pharmacist compensation; 2) hesitation among providers to trust pharmacists; 3) lack of time and resources; and 4) existing informal collaborations that resulted in reduced interest in formal agreements. The models described in this study could be used to strengthen clinical–community linkages through team-based care, particularly for chronic disease prevention and management. Centers for Disease Control and Prevention 2015-03-26 /pmc/articles/PMC4375988/ /pubmed/25811494 http://dx.doi.org/10.5888/pcd12.140504 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Special Topic
Snyder, Margie E.
Earl, Tara R.
Gilchrist, Siobhan
Greenberg, Michael
Heisler, Holly
Revels, Michelle
Matson-Koffman, Dyann
Collaborative Drug Therapy Management: Case Studies of Three Community-Based Models of Care
title Collaborative Drug Therapy Management: Case Studies of Three Community-Based Models of Care
title_full Collaborative Drug Therapy Management: Case Studies of Three Community-Based Models of Care
title_fullStr Collaborative Drug Therapy Management: Case Studies of Three Community-Based Models of Care
title_full_unstemmed Collaborative Drug Therapy Management: Case Studies of Three Community-Based Models of Care
title_short Collaborative Drug Therapy Management: Case Studies of Three Community-Based Models of Care
title_sort collaborative drug therapy management: case studies of three community-based models of care
topic Special Topic
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4375988/
https://www.ncbi.nlm.nih.gov/pubmed/25811494
http://dx.doi.org/10.5888/pcd12.140504
work_keys_str_mv AT snydermargiee collaborativedrugtherapymanagementcasestudiesofthreecommunitybasedmodelsofcare
AT earltarar collaborativedrugtherapymanagementcasestudiesofthreecommunitybasedmodelsofcare
AT gilchristsiobhan collaborativedrugtherapymanagementcasestudiesofthreecommunitybasedmodelsofcare
AT greenbergmichael collaborativedrugtherapymanagementcasestudiesofthreecommunitybasedmodelsofcare
AT heislerholly collaborativedrugtherapymanagementcasestudiesofthreecommunitybasedmodelsofcare
AT revelsmichelle collaborativedrugtherapymanagementcasestudiesofthreecommunitybasedmodelsofcare
AT matsonkoffmandyann collaborativedrugtherapymanagementcasestudiesofthreecommunitybasedmodelsofcare